#13#

 

Revisiones-Ciencias Básicas-Microorganismos *** Reviews-Basic Sciences-Microorganisms

 

INMUNOSUPRESIÓN *** IMMUNOSUPPRESSION

(Conceptos / Keywords: Immunosuppression; Immunosuppressive ag.; Transpl. immunol.; GVH; Antirejection therapy; Lymphocyte depletion; Transpl. conditioning; etc).

 

Enero / January 2001 --- Marzo / March 2004

 

La biblioteca del conocimiento biomédico© es un servicio GRATUITO. Toda la información ha sido obtenida de fuentes públicas, de portales de internet que no requieren registro alguno para su uso, que no requieren estar de acuerdo con sus Términos de uso, que son de libre acceso a todo el mundo, y son a su vez gratuitos. La biblioteca (revisiones, guías, protocolos, medicina basada en la evidencia, etc...) se recopila en base a una patente que permite a Effiloop la catalogación de los artículos por campos de interés así como por el orden de su importancia (se proveen las primeras 200 revisiones). Toda la informacion se ampara en las leyes de libre pensamiento-expresión, y de uso justo. Este documento sólo contiene artículos escritos en Castellano y/o Inglés.

 

The biomedical library© is a FREE service. All the information has been obtained from public sources, from web sites that do not require registration for their use, that do not require an agreement with their Terms of use, that provide free access for all, and are free of charge. The library (reviews, guides, protocols, medicine based medicine, etc) is arranged according to a patent that warrants Effiloop to catalogue the articles by fields of interest as well as to sort articles by true relevance (the first 200 reviews are provided). All the information is provided according to the freedom of speech and fair use laws. Only articles written in Spanish and/or English are included.

Enlace / Link

 

[1]

TÍTULO / TITLE:  - Immunopathogenesis and immunotherapy in AIDS virus infections.

REVISTA / JOURNAL:  - Nat Med 2003 Jul;9(7):861-6.

      ●● Enlace al texto completo (gratuito o de pago) 1038/nm0703-861

AUTORES / AUTHORS:  - Letvin NL; Walker BD

INSTITUCIÓN / INSTITUTION:  - Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.

RESUMEN / SUMMARY:  - The heterogeneity of HIV and the different human leukocyte antigen (HLA) backgrounds of infected individuals have posed challenges to understanding the pathogenesis of HIV infection. But continuing advances in our knowledge of the role of immune responses in controlling HIV viremia should help to define goals for immune-based therapies and vaccine strategies against AIDS.  N. Ref:: 106

 

----------------------------------------------------

[2]

TÍTULO / TITLE:  - Defying death—HIV mutation to evade cytotoxic T lymphocytes.

REVISTA / JOURNAL:  - N Engl J Med. Acceso gratuito al texto completo a partir de los 6 meses de la fecha de publicación.

      ●● Enlace a la Editora de la Revista http://content.nejm.org/ 

      ●● Cita: New England J Medicine (NEJM): <> 2002 Oct 10;347(15):1203-4.

      ●● Enlace al texto completo (gratuito o de pago) 1056/NEJMcibr022067

AUTORES / AUTHORS:  - Lieberman J

INSTITUCIÓN / INSTITUTION:  - Center for Blood Research, Boston, MA 02115, USA.  N. Ref:: 5

 

----------------------------------------------------

[3]

TÍTULO / TITLE:  - Effects of MHC class I on HIV/SIV disease in primates.

REVISTA / JOURNAL:  - AIDS 2002;16 Suppl 4:S105-14.

AUTORES / AUTHORS:  - Carrington M; Bontrop RE

INSTITUCIÓN / INSTITUTION:  - Basic Research Program, SAIC Frederick, National Cancer Institute, Frederick, MD 21702, USA. carringt@ncifcrf.gov

RESUMEN / SUMMARY:  - Data indicate that resistance to HIV-1 disease involves an array of contrasting HLA genotypic effects that are subtle, but significant, particularly when these genetic effects are considered as a whole. Numerous reports attributing a role for HLA genotype in AIDS outcomes have been reported, and a few of these have been affirmed in multiple studies. Functional studies of immune cell recognition have provided clues to the underlying mechanisms behind some of the strongest HLA associations, suggesting the means by which relative resistance or susceptibility to the virus may occur. SIV infection in non-human primates has served as an invaluable model for understanding AIDS pathogenesis (in rhesus monkeys) and viral resistance (in chimpanzee). The effect of rhesus MHC class I molecules on the evolution of SIV has been convincingly described [19], and a recent study in humans has suggested that selection pressure conferred by HLA molecules is responsible for specific genetic variation in HIV-1 [114]. HIV-1 may eventually have conspicuous evolutionary effects on HLA and other AIDS restriction genes, a prolonged process that could have occurred in chimpanzee [92].To prevent such an outcome, it will be necessary to approach the disease from many perspectives, andapply comprehensively the knowledge gained to the successful control of the virus.  N. Ref:: 114

 

----------------------------------------------------

[4]

TÍTULO / TITLE:  - Virus evasion of MHC class I molecule presentation.

REVISTA / JOURNAL:  - J Immunol. Acceso gratuito al texto completo a partir de 1 año de la fecha de publicación.

      ●● Enlace a la Editora de la Revista http://www.jimmunol.org/ 

      ●● Cita: J. of Immunology: <> 2003 Nov 1;171(9):4473-8.

AUTORES / AUTHORS:  - Petersen JL; Morris CR; Solheim JC

INSTITUCIÓN / INSTITUTION:  - Eppley Institute for Research in Cancer and Allied Diseases, Omaha, NE 68198-6805, USA.  N. Ref:: 97

 

----------------------------------------------------

[5]

TÍTULO / TITLE:  - Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.

REVISTA / JOURNAL:  - J Infect 2004 Jan;48(1):112-6.

AUTORES / AUTHORS:  - Steinbach WJ; Schell WA; Miller JL; Perfect JR; Martin PL

INSTITUCIÓN / INSTITUTION:  - Division of Pediatric Infectious Diseases, Department of Pediatrics, Duke University Medical Center, Box 3499, Durham, NC, USA. stein022@mc.duke.edu  N. Ref:: 33

 

----------------------------------------------------

[6]

TÍTULO / TITLE:  - Dendritic cells transduced with viral interleukin 10 or Fas ligand: no evidence for induction of allotolerance in vivo.

REVISTA / JOURNAL:  - Transplantation 2002 Jan 15;73(1 Suppl):S27-30.

AUTORES / AUTHORS:  - Buonocore S; Van Meirvenne S; Demoor FX; Paulart F; Thielemans K; Goldman M; Flamand V

INSTITUCIÓN / INSTITUTION:  - 2 Laboratory of Physiology, Medical School of Vrije Universiteit Brussel.

RESUMEN / SUMMARY:  - Dendritic cells (DC) are the most potent presenters of alloantigens and therefore are responsible for the induction of allograft rejection. Genetic modifications of DC allowing the expression of a tolerogenic molecule may render them immunosuppressive. We transduced bone marrow-derived DC with recombinant MFG retrovirus encoding either viral interleukin (vIL)-10 or Fas ligand (FasL) to induce transplantation tolerance. Up to 10 ng/ml of bioactive vIL-10 was produced by DC after transfer of the corresponding gene. Although the inhibitory properties of vIL-10-transduced DC were revealed in vitro in a mixed lymphocyte culture, no clear down-regulation of the allogeneic response was observed in vivo after single or multiple injections of those DC overexpressing vIL-10. When we transduced wild-type bone marrow-derived DC with recombinant MFG retrovirus encoding murine FasL, cells quickly died, probably because of suicidal or fratricidal Fas-dependent death. Indeed, only DC from Fas-deficient lpr mice survived to FasL gene transfer. Those FasL-transduced lpr DC exhibited a strong cytotoxic activity against Fas-positive targets in vitro. DC overexpressing FasL did not behave as immunosuppressive DC in vivo. The subcutaneous injection of FasL+ lpr DC in MHC class II-disparate mice hyperactivated the allospecific proliferation of T cells in the draining lymph nodes compared with mice treated with control-transduced DC. These results argue against the development of FasL+ DC or vIL-10-secreting DC as immunosuppressive tools in vivo. The alternative pathways of T-cell activation triggered by these genetically modified DC need to be investigated.  N. Ref:: 20

 

----------------------------------------------------

[7]

TÍTULO / TITLE:  - Penicillin-resistant Streptococcus pneumoniae septic shock and meningitis complicating chronic graft versus host disease: a case report and review of the literature.

REVISTA / JOURNAL:  - Am J Med 2002 Aug 1;113(2):152-5.

AUTORES / AUTHORS:  - Haddad PA; Repka TL; Weisdorf DJ

INSTITUCIÓN / INSTITUTION:  - Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, USA.  N. Ref:: 34

 

----------------------------------------------------

[8]

TÍTULO / TITLE:  - Cross-presentation in viral immunity and self-tolerance.

REVISTA / JOURNAL:  - Nat Rev Immunol 2001 Nov;1(2):126-34.

      ●● Enlace al texto completo (gratuito o de pago) 1038/35100512

AUTORES / AUTHORS:  - Heath WR; Carbone FR

INSTITUCIÓN / INSTITUTION:  - Immunology Division, The Walter and Eliza Hall Institute, Melbourne Hospital, Parkville, Victoria, Australia. heath@wehi.edu.au

RESUMEN / SUMMARY:  - T lymphocytes recognize peptide antigens presented by class I and class II molecules encoded by the major histocompatibility complex (MHC). Classical antigen-presentation studies showed that MHC class I molecules present peptides derived from proteins synthesized within the cell, whereas MHC class II molecules present exogenous proteins captured from the environment. Emerging evidence indicates, however, that dendritic cells have a specialized capacity to process exogenous antigens into the MHC class I pathway. This function, known as cross-presentation, provides the immune system with an important mechanism for generating immunity to viruses and tolerance to self.  N. Ref:: 83

 

----------------------------------------------------

[9]

TÍTULO / TITLE:  - Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide.

REVISTA / JOURNAL:  - J Clin Microbiol. Acceso gratuito al texto completo a partir de los 6 meses de la fecha de publicación.

      ●● Enlace a la Editora de la Revista http://jcm.asm.org/ 

      ●● Cita: J. Clinical Microbiology: <> 2003 Aug;41(8):3981-5.

AUTORES / AUTHORS:  - Steinbach WJ; Schell WA; Miller JL; Perfect JR

INSTITUCIÓN / INSTITUTION:  - Department of Pediatrics, Duke University, Durham, North Carolina 27710, USA. stein022@mc.duke.edu

RESUMEN / SUMMARY:  - Scedosporium species are increasingly isolated from immunocompromised and immunocompetent patients. Unfortunately, Scedosporium infections are generally resistant to amphotericin B, and Scedosporium prolificans strains are particularly resistant to the antifungal agents now in use. We report here on an immunocompetent child with S. prolificans-associated osteomyelitis successfully treated with debridement, local irrigation with polyhexamethylene biguanide, and the systemic administration of voriconazole and caspofungin despite poor in vitro activity of voriconazole alone against the isolate. We also review the treatments and outcomes of 28 reported cases of osteomyelitis or septic arthritis caused by Scedosporium species in immunocompetent patients.  N. Ref:: 62

 

----------------------------------------------------

[10]

TÍTULO / TITLE:  - Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection.

REVISTA / JOURNAL:  - Rheumatology (Oxford). Acceso gratuito al texto completo a partir de los 2 años de la fecha de publicación.

      ●● Enlace a la Editora de la Revista http://rheumatology.oupjournals.org/ 

      ●● Cita: Rheumatology (Oxford): <> 2003 Jul;42(7):818-28. Epub 2003 Apr 16.

      ●● Enlace al texto completo (gratuito o de pago) 1093/rheumatology/keg299

AUTORES / AUTHORS:  - Ramos-Casals M; Trejo O; Garcia-Carrasco M; Font J

INSTITUCIÓN / INSTITUTION:  - Department of Autoimmune Diseases, Clinical Institutes of Infection and Immunology, Insitut d’Investigacions Biomediques August Pi i Sunyer, Hospital Clinic, Department of Medicine, School of Medicine, University of Barcelona, España. mramos@clinic.ub.es  N. Ref:: 123

 

----------------------------------------------------

[11]

TÍTULO / TITLE:  - Clinical protocol. Purging of autologous stem cell sources with bcl-x(s) adenovirus for women undergoing high-dose chemotherapy for stage IV breast carcinoma.

REVISTA / JOURNAL:  - Hum Gene Ther 2001 Nov 1;12(16):2023-5.

AUTORES / AUTHORS:  - Ayash LJ; Clarke M; Adams P; Ferrara J; Ratanatharathorn V; Reynolds C; Roessler B; Silver S; Strawderman M; Uberti J; Wicha M

RESUMEN / SUMMARY:  - High-dose chemotherapy (HDCT) and autologous bone marrow transplantation (BMT) is frequently used to treat patients with metastatic cancer including breast cancer and neuroblastoma. However, the bone marrow of such patients is often contaminated with tumor cells. Recently, we have found that a recombinant adenovirus vector that contains a bcl-x, minigene (a dominant negative inhibitor of the bcl-2 family), called the bcl-x(s) adenovirus, is lethal to cancer cells derived from epithelial tissues, but not to normal human hematopoietic cells. To determine the mechanism, by which this virus spares normal hematopoietic cells, we isolated normal mouse hematopoietic stem cells and infected them with an adenovirus that contains a beta-galactosidase minigene. Such cells do not express beta-galactosidase, indicating that hematopoietic stem cells do not express transgene encoded by adenovirus vectors based upon the RSV-AD5 vector system. When breast cancer cells mixed with hematopoietic cells were infected with the bcl-x(s) adenovirus, cancer cells were selectively killed by the suicide adenoviruses. Hematopoietic cells exposed to the suicide vectors were able to reconstitute the bone marrow of mice exposed to lethal doses of y-irradiation. These studies suggest that adenovirus suicide vectors may provide a simple and effective method to selectively eliminate cancer cells derived from epithelial tissue that contaminate bone marrow to be used for autologous BMT. We therefore propose to initiate a phase I clinical trial to test the safety of this virus in women with breast cancer undergoing high does chemotherapy and autologous BMT.

 

----------------------------------------------------

[12]

TÍTULO / TITLE:  - Regulation of gene expression in lymphocytes and antigen-presenting cells by measles virus: consequences for immunomodulation.

REVISTA / JOURNAL:  - J Mol Med 2002 Feb;80(2):73-85. Epub 2001 Nov 15.

      ●● Enlace al texto completo (gratuito o de pago) 1007/s00109-001-0299-x

AUTORES / AUTHORS:  - Schneider-Schaulies S; Bieback K; Avota E; Klagge I; ter Meulen V

INSTITUCIÓN / INSTITUTION:  - Institute for Virology and Immunobiology, University of Wurzburg, Versbacher Strasse 7, 97078 Wurzburg, Germany. s-s-s@vim.uni-wuerzburg.de

RESUMEN / SUMMARY:  - Acute measles, a well known disease usually contracted during early childhood, is still the major cause of vaccine-preventable infant deaths worldwide. There are about 40 million cases of acute measles per year, with more than one million cases of infant death as a consequence of measles. These are mainly due to opportunistic infections which develop on the basis of a generalized suppression of the cellular immunity in the course and after the acute disease. Lymphopenia, a general proliferative unresponsiveness of T cells ex vivo and cytokine imbalance, are considered as major hallmarks of measles virus (MV) induced immunosuppression. These findings are compatible with modulation of T cell responses by viral interference with professional antigen-presenting cells such as dendritic cells or direct effects on T cells by suppression of survival or proliferation signals. In vitro, MV interaction causes a variety of effects on dendritic cells, including maturation and loss of their allostimulatory functions. Whether there is an additional impact on the quality of T cell responses is unknown as yet. It is clear, however, that surface interaction of lymphocytes with the MV glycoprotein complex is necessary and sufficient to induce a state of proliferative unresponsiveness in T cells. This surface contact mediated signal essentially interferes with the propagation of the interleukin 2 receptor signal by blocking the activation of the protein kinase B, also called Akt kinase, both in vitro and after experimental infection.  N. Ref:: 122

 

----------------------------------------------------

[13]

TÍTULO / TITLE:  - Severe Ehrlichia chaffeensis infection in a lung transplant recipient: a review of ehrlichiosis in the immunocompromised patient.

REVISTA / JOURNAL:  - Emerg Infect Dis. Acceso gratuito al texto completo.

      ●● Enlace a la Editora de la Revista http://www.cdc.gov/ 

      ●● Cita: Emerging Infectious Diseases: <> 2002 Mar;8(3):320-3.

AUTORES / AUTHORS:  - Safdar N; Love RB; Maki DG

INSTITUCIÓN / INSTITUTION:  - Section of Infectious Diseases, University of Wisconsin Medical School, 600 Highland Avenue, Madison, WI 53792, USA.

RESUMEN / SUMMARY:  - We describe a case of human ehrlichiosis in a lung transplant recipient and review published reports on ehrlichiosis in immunocompromised patients. Despite early therapy with doxycycline, our patient had unusually severe illness with features of thrombotic thrombocytopenic purpura. Of 23 reported cases of ehrlichiosis in immunocompromised patients, organ failure occurred in all patients and 6 (25%) died.  N. Ref:: 32

 

----------------------------------------------------

[14]

TÍTULO / TITLE:  - Subcutaneous black fungus (phaeohyphomycosis) infection in renal transplant recipients:three cases.

REVISTA / JOURNAL:  - Transplantation 2004 Jan 15;77(1):140-2.

      ●● Enlace al texto completo (gratuito o de pago) 1097/01.TP.0000107287.70512.E7

AUTORES / AUTHORS:  - Yehia M; Thomas M; Pilmore H; Van Der Merwe W; Dittmer I

INSTITUCIÓN / INSTITUTION:  - Auckland Renal Transplant Group, Auckland Hospital, Auckland, New Zealand. mahay@adhb.govt.nz

RESUMEN / SUMMARY:  - We describe three cases of subcutaneous phaeohyphomycosis developing in the lower limbs of renal transplant recipients shortly after transplantation. Each case presented with dark-colored nodules that subsequently ulcerated. Histopathologic examination revealed dematiaceous fungal hyphae with a surrounding granulomatous reaction. The fungi were subsequently identified as Alternaria alternatum in two cases and Phialophora richardsiae in one case. In one case, the lesions resolved during a prolonged (6-month) course of itraconazole without the requirement for surgical excision. In the other two cases, combined medical and surgical treatment resulted in cure. A review of the literature on phaeohyphomycosis is presented.  N. Ref:: 11

 

----------------------------------------------------

[15]

TÍTULO / TITLE:  - Vascular thrombosis and acute cytomegalovirus infection in immunocompetent patients: report of 2 cases and literature review.

REVISTA / JOURNAL:  - Clin Infect Dis 2003 Jun 1;36(11):E134-9. Epub 2003 May 19.

AUTORES / AUTHORS:  - Abgueguen P; Delbos V; Chennebault JM; Payan C; Pichard E

INSTITUCIÓN / INSTITUTION:  - Department of Infectious Diseases, Centre Hospitalo-Universitaire, Angers, France. piabgueguen@chu-angers.fr

RESUMEN / SUMMARY:  - Acute cytomegalovirus (CMV) infection in immunocompetent patients is common worldwide, with seroprevalence rates of 40%-100%, depending on the country, socioeconomic conditions, and the patient’s age. Infection is most often asymptomatic, but acute cytomegalovirus infection is occasionally revealed by prolonged fever, cervical lymphadenitis, and arthralgia, and it is more rarely revealed by pneumonia, myocarditis, pericarditis, colitis, and hemolytic anemia. Here, we report 2 cases of acute CMV infection in nonimmunocompromised adults that were complicated by venous thrombosis with pulmonary embolism. We also review previously reported cases of vascular thrombosis and discuss the propensity of CMV to induce vascular damage with associated thrombosis.  N. Ref:: 55

 

----------------------------------------------------

[16]

TÍTULO / TITLE:  - The fission yeast TOR proteins and the rapamycin response: an unexpected tale.

REVISTA / JOURNAL:  - Curr Top Microbiol Immunol 2004;279:85-95.

AUTORES / AUTHORS:  - Weisman R

INSTITUCIÓN / INSTITUTION:  - Department of Molecular Microbiology and Biotechnology, Faculty of Life Sciences, Tel-Aviv University, 69978 Tel-Aviv, Israel. ronitt@post.tau.ac.il

RESUMEN / SUMMARY:  - The TOR proteins are known as key regulators of cell growth in response to nutritional and mitogenic signals and as targets for the immunosuppressive and anti-cancerous drug rapamycin. The fission yeast Schizosaccharomyces pombe has two TOR homologues, tor1+ and tor2+. Despite their structural similarity, these genes have distinct functions: tor1+ is required under starvation, extreme temperatures, and osmotic or oxidative stress conditions, whereas tor2+ is required under normal growth conditions. Surprisingly, rapamycin does not seem to inhibit the S. pombe TOR-related functions. Rapamycin specifically inhibits sexual development in S. pombe, and this seems to stem from direct inhibition of the S. pombe FKBP12 homologue. Why S. pombe cells are resistant to rapamycin during the growth phase is as yet unclear and awaits further analysis of the TOR-dependent signaling pathways.  N. Ref:: 27

 

----------------------------------------------------

[17]

TÍTULO / TITLE:  - Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials.

REVISTA / JOURNAL:  - Vaccine 2001 Sep 14;19(32):4780-90.

AUTORES / AUTHORS:  - Cornu C; Yzebe D; Leophonte P; Gaillat J; Boissel JP; Cucherat M

INSTITUCIÓN / INSTITUTION:  - Service of Clinical Pharmacology, EA643, Lyon University Hospital, Faculte de Medicine RTH Laennec, BP 8071, 69376, Cedex 08, Lyon, France. catherine.cornu@upcl.univ-lyon1.fr

RESUMEN / SUMMARY:  - The use of pneumococcal polysaccharide vaccine (PPV) is low in some countries, maybe because of doubts regarding its efficacy. This meta-analysis aims at combining evidence from randomized trials of PPV assessing its efficacy in preventing Streptococcus pneumoniae related diseases in immunocompetent adults. In the fourteen trials totalling 48,837 patients retrieved, PPV prevents definite pneumococcal pneumonia by 71%, presumptive pneumococcal pneumonia by 40%, and mortality due to pneumonia by 32%, but not all-cause pneumonia or death. No preventive effect was seen in the subgroup of patients aged 55 years or more, possibly due to a lack of statistical power.

 

----------------------------------------------------

[18]

TÍTULO / TITLE:  - Disseminated ochroconis gallopavum infection in a renal transplant recipient: the first reported case and a review of the literature.

REVISTA / JOURNAL:  - Clin Nephrol 2003 Dec;60(6):415-23.

AUTORES / AUTHORS:  - Wang TK; Chiu W; Chim S; Chan TM; Wong SS; Ho PL

INSTITUCIÓN / INSTITUTION:  - Centre of Infection, Department of Microbiology, Queen Mary Hospital, University of Hong Kong, Hong Kong, SAR, China.

RESUMEN / SUMMARY:  - Ochroconis gallopavum is a potentially fatal dematiaceous fungus causing opportunistic infections in immunocompromised hosts. We report the first case of disseminated O. gallopavum infection in a 13-year-old renal transplant recipient, which involved the brain, lung and spleen. He was treated with amphotericin B, itraconazole and voriconazole, a new antifungal agent first used to treat such an infection. Besides antifungal treatment, all immunosuppressive agents were stopped and automated peritoneal dialysis was resumed. The initial infection was under control with both clinical and radiological improvements after treatment. However, the patient later acquired Acremonium spp. peritonitis; he failed to respond to high-dose amphotericin B, and finally succumbed. A total of 13 reported O. gallopavum human infections, including the one described here, are reviewed. The most common site of involvement is the brain and the crude mortality rate is up to 46%. As the disease is potentially lethal in immunocompromised hosts, empirical antifungal coverage should be considered in post-renal transplant recipients with suspected brain abscess. Early biopsy of lesion for histopathological and microbiological diagnosis would be essential in managing such cases.  N. Ref:: 23

 

----------------------------------------------------

[19]

TÍTULO / TITLE:  - The HCMV gene products US2 and US11 target MHC class I molecules for degradation in the cytosol.

REVISTA / JOURNAL:  - Curr Top Microbiol Immunol 2002;269:37-55.

AUTORES / AUTHORS:  - van der Wal FJ; Kikkert M; Wiertz E

INSTITUCIÓN / INSTITUTION:  - Department of Medical Microbiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands.

RESUMEN / SUMMARY:  - Over millions of years of coevolution with their hosts, viruses have developed highly effective strategies to elude the host immune system. The degradation of major histocompatibility complex (MHC) class I heavy chains by human cytomegalovirus (HCMV) is an example of this. Two HCMV proteins, US2 and US11, target newly synthesized MHC class I heavy chains for destruction via a pathway that involves ubiquitin-dependent retrograde transport, or “dislocation”, of the heavy chains from the ER to the cytosol, where the proteins are degraded by proteasomes. In this review, US2- and US11-mediated degradation of MHC class I heavy chains is discussed in relation to data concerning the degradation of other ER luminal proteins. A new, unified model for translocon-facilitated dislocation and degradation of MHC class I heavy chains is presented.  N. Ref:: 115

 

----------------------------------------------------

[20]

TÍTULO / TITLE:  - Beta-herpesvirus challenges in the transplant recipient.

REVISTA / JOURNAL:  - J Infect Dis. Acceso gratuito al texto completo a partir de los 2 años de la publicación;  - http://www.journals.uchicago.edu/ 

      ●● Cita: J. of Infectious Diseases: <> 2002 Oct 15;186 Suppl 1:S99-S109.

AUTORES / AUTHORS:  - Ljungman P

INSTITUCIÓN / INSTITUTION:  - Karolinska Institutet, SE-14186 Stockholm, Sweden. per.ljungman@medhs.ki.se

RESUMEN / SUMMARY:  - Cytomegalovirus (CMV) has major consequences after allogeneic stem cell and solid organ transplantation. CMV may cause significant morbidity and mortality, and monitoring to detect reactivation to reduce disease or management of end organ disease is associated with increased resource utilization. Two other members of the beta-herpesvirus family, human herpesvirus (HHV) type 6 and HHV-7, are increasingly recognized as important pathogens in transplant recipients, either by direct infection (e.g., encephalitis, hepatitis, or pneumonitis) or via interaction with CMV. In addition to direct effects of CMV infection, such indirect effects as an increased risk for bacterial and fungal infections or impaired graft acceptance and function are important research topics. Diagnosis and treatment of CMV infection is currently more advanced than for HHV-6 and HHV-7.  N. Ref:: 109

 

----------------------------------------------------

[21]

TÍTULO / TITLE:  - Cellular engineering of HSV-tk transduced, expanded T lymphocytes for graft-versus-host disease management.

REVISTA / JOURNAL:  - Acta Haematol 2003;110(2-3):121-31.

      ●● Enlace al texto completo (gratuito o de pago) 1159/000072461

AUTORES / AUTHORS:  - Burger SR; Kadidlo DM; Basso L; Bostrom N; Orchard PJ

INSTITUCIÓN / INSTITUTION:  - Advanced Cell and Gene Therapy, Chapel Hill, NC 27516, USA. sburger@ac-gt.com

RESUMEN / SUMMARY:  - Engineering donor T lymphocytes with inducible ‘suicide genes’, such as herpes simplex virus thymidine kinase, has potential to improve safety and efficacy in allogeneic transplantation by facilitating management of graft-versus-host disease. Elective administration of a relatively nontoxic pro-drug would induce in vivo negative selection of engineered lymphocytes specifically, sparing other donor hematopoietic cells. The engineered cells must retain immunologic function, and undergo negative selection in response to clinically attainable plasma concentrations of pro-drug. The cell engineering process itself, typically involving activation, transduction, ex vivo expansion, and selection, must produce clinically useful numbers of genetically modified cells at high purity. We discuss development of a cellular engineering manufacturing process that yields transduced, expanded T lymphocytes meeting these requirements.  N. Ref:: 37

 

----------------------------------------------------

[22]

TÍTULO / TITLE:  - Host and viral genetics and risk of cervical cancer: a review.

REVISTA / JOURNAL:  - Virus Res 2002 Nov;89(2):229-40.

AUTORES / AUTHORS:  - Hildesheim A; Wang SS

INSTITUCIÓN / INSTITUTION:  - Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Room 7062, EPS/MSC# 7234, Rockville, MD 20852, USA. hildesha@exchange.nih.gov

RESUMEN / SUMMARY:  - Infection with human papillomaviruses (HPV) is known to play a central role in the development of cervical cancer. Both host and viral genetic factors have been postulated to be important determinants of risk of HPV progression to neoplasia among infected individuals. In this report, we review epidemiological studies that have evaluated the role in cervical cancer pathogenesis of genetic variation in human leukocyte antigen (HLA) genes and in the HPV genome itself. A protective effect of HLA Class II DRB1*13/DBQ1*0603 alleles is the most consistent HLA finding in the published literature. A consistent association between HPV16 non-European variants and risk of disease is also evident from published work. These findings are discussed. Gaps in our understanding and future research needs are also discussed.  N. Ref:: 90

 

----------------------------------------------------

[23]

TÍTULO / TITLE:  - Successful management of disseminated Nocardia transvalensis infection in a heart transplant recipient after development of sulfonamide resistance: case report and review.

REVISTA / JOURNAL:  - J Heart Lung Transplant 2003 Apr;22(4):492-7.

AUTORES / AUTHORS:  - Lopez FA; Johnson F; Novosad DM; Beaman BL; Holodniy M

INSTITUCIÓN / INSTITUTION:  - Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.

RESUMEN / SUMMARY:  - Nocardia transvalensis is a rarely reported cause of clinically significant disease, and, to our knowledge, has not been reported previously as a cause of infection in the cardiac transplant population. We report a case of N transvalensis new taxon-2 pulmonary infection that disseminated to the brain and skin in a cardiac transplant recipient despite adequate sulfonamide serum levels. Subsequent isolates were resistant to sulfonamides, and molecular ribotyping of the primary and subsequent isolates confirmed that these were the same N transvalensis new taxon-2 strain. The taxonomic and diagnostic considerations, as well as the clinical significance of anti-microbial-resistant nocardia, are reviewed and discussed herein.  N. Ref:: 37

 

----------------------------------------------------

[24]

TÍTULO / TITLE:  - Acremonium strictum pulmonary infection in a leukemic patient successfully treated with posaconazole after failure of amphotericin B.

REVISTA / JOURNAL:  - Eur J Clin Microbiol Infect Dis 2002 Nov;21(11):814-7. Epub 2002 Oct 31.

      ●● Enlace al texto completo (gratuito o de pago) 1007/s10096-002-0828-8

AUTORES / AUTHORS:  - Herbrecht R; Letscher-Bru V; Fohrer C; Campos F; Natarajan-Ame S; Zamfir A; Waller J

INSTITUCIÓN / INSTITUTION:  - Departement d’Hematologie et d’Oncologie, Hopital de Hautepierre, Avenue Moliere, 67098 Strasbourg, France. raoul.herbrecht@chru-strasbourg.fr

RESUMEN / SUMMARY:  - A severely neutropenic patient with chronic lymphocytic leukemia developed a diffuse bilateral pulmonary infection while receiving a therapeutic daily dosage of intravenous amphotericin B for Candida glabrata esophagitis. Computed tomography of the chest showed numerous lung nodules, ground glass areas and a pleural effusion. Biopsy of one nodule demonstrated hyaline septate hyphae. Multiple sputum cultures grew Acremonium strictum. Increasing the dose of amphotericin B and the addition of itraconazole did not resolve the infection. Change of treatment to posaconazole given orally at 200 mg four times/d resulted in progressive improvement leading finally to cure after 24 weeks of therapy. Treatment with posaconazole was clinically and biologically well tolerated.  N. Ref:: 15

 

----------------------------------------------------

[25]

TÍTULO / TITLE:  - Prevention of cytomegalovirus disease in recipients of solid-organ transplants.

REVISTA / JOURNAL:  - Clin Infect Dis 2001 Feb 15;32(4):596-603. Epub 2001 Feb 6.

AUTORES / AUTHORS:  - Paya CV

INSTITUCIÓN / INSTITUTION:  - Division of Infectious Diseases and Transplant Center, Mayo Clinic, Rochester, MN 55905. USA. paya@mayo.edu

RESUMEN / SUMMARY:  - The introduction and combination of more-potent immunosuppressive regimens, and the increased transplantation of organs into more severely ill patients, have again placed cytomegalovirus (CMV) disease in the spotlight of posttransplantation complications. Both direct and associated complications related to CMV need to be considered in understanding the pathogenesis of CMV infection after solid-organ transplantation. New diagnostic methods with higher sensitivity for the detection of CMV and the ability to quantify CMV indicate that low levels of CMV replication are present in many patients who don’t have clinical symptoms ascribed to CMV infection. How these low levels of CMV replication impact the outcome of the transplanted graft remains unknown. In addition, there needs to be further study regarding whether only patients at high risk for developing CMV disease or, also, those with clinically asymptomatic levels of CMV replication should be the target of effective preventive regimens. This review summarizes our current knowledge of the pathogenesis of CMV infection after solid-organ transplantation, and it outlines different effective preventive regimens and approaches.  N. Ref:: 47

 

----------------------------------------------------

[26]

TÍTULO / TITLE:  - Common community respiratory viruses in patients with cancer: more than just “common colds”.

REVISTA / JOURNAL:  - Cancer 2003 May 15;97(10):2576-87.

      ●● Enlace al texto completo (gratuito o de pago) 1002/cncr.11353

AUTORES / AUTHORS:  - Hicks KL; Chemaly RF; Kontoyiannis DP

INSTITUCIÓN / INSTITUTION:  - Department of Bone Marrow Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

RESUMEN / SUMMARY:  - Community respiratory viruses long have been recognized as primary respiratory pathogens among infants and young children. More recently, it has become clear that these viruses cause a considerable disease burden throughout life. The consequences of repeated infections are most evident in elderly and immunocompromised persons. Even in otherwise healthy persons, reinfections often require medical attention but generally are undiagnosed and unrecognized. These reinfections may spread from healthy persons to those at highest risk. Control requires a multifaceted approach combining vaccination, chemoprophylaxis, and aggressive early antiviral treatment of high-risk individuals, as well as education of all populations affected by these viruses.  N. Ref:: 90

 

----------------------------------------------------

[27]

TÍTULO / TITLE:  - Immune control of HIV: the obstacles of HLA and viral diversity.

REVISTA / JOURNAL:  - Nat Immunol 2001 Jun;2(6):473-5.

      ●● Enlace al texto completo (gratuito o de pago) 1038/88656

AUTORES / AUTHORS:  - Walker BD; Korber BT

INSTITUCIÓN / INSTITUTION:  - Partners AIDS Research Center, Massachusetts General Hospital and Division of AIDS, Harvard Medical School, Boston, MA 02114, USA. bwalker@helix.mgh.harvard.edu  N. Ref:: 27

 

----------------------------------------------------

[28]

TÍTULO / TITLE:  - Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate.

REVISTA / JOURNAL:  - Mayo Clin Proc. Acceso gratuito al texto completo.

      ●● Enlace a la Editora de la Revista http://www.mayo.edu/proceedings/ 

      ●● Cita: Mayo Clinic Proceedings: <> 2001 Aug;76(8):845-8.

AUTORES / AUTHORS:  - Tournadre A; D’Incan M; Dubost JJ; Franck F; Dechelotte P; Souteyrand P; Soubrier M

INSTITUCIÓN / INSTITUTION:  - Department of Rheumatology, Hjpital Gabriel Montpied, Clermont-Ferrand, France.

RESUMEN / SUMMARY:  - Whether patients with rheumatoid arthritis (RA) have an increased risk of developing non-Hodgkin lymphoma is controversial, and opinions differ on the possible role of methotrexate in the occurrence of lymphomas in patients with RA. We report 1 T-cell lymphoma and 1 B-cell lymphoma restricted to the skin associated with Epstein-Barr virus infection that healed completely and spontaneously after discontinuation of methotrexate in a man with RA and a woman with dermatomyositis. Cutaneous infiltrating cells were infected by a replicative form of Epstein-Barr virus. After discontinuation of methotrexate, the cutaneous lesions disappeared completely in 15 days without recurrence. Discontinuation of methotrexate is necessary in patients with RA or dermatomyositis who have a lymphoproliferative disorder, and a follow-up period of several weeks should be observed before specific therapy is initiated.  N. Ref:: 18

 

----------------------------------------------------

[29]

TÍTULO / TITLE:  - Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies.

REVISTA / JOURNAL:  - Arthritis Rheum 2002 Mar;46(3):585-97.

      ●● Enlace al texto completo (gratuito o de pago) 1002/art.10107 [pii

      ●● Enlace al texto completo (gratuito o de pago) 1002/art.10107

AUTORES / AUTHORS:  - Vassilopoulos D; Calabrese LH

INSTITUCIÓN / INSTITUTION:  - Hippokration General Hospital, Athens University, Athens, Greece.  N. Ref:: 92

 

----------------------------------------------------

[30]

TÍTULO / TITLE:  - Retroviral proteins that target the major histocompatibility complex class I.

REVISTA / JOURNAL:  - Virus Res 2002 Sep;88(1-2):119-27.

AUTORES / AUTHORS:  - Johnson JM; Franchini G

INSTITUCIÓN / INSTITUTION:  - National Cancer Institute, Basic Research Laboratory, 41/D804, Bethesda, MD 20892-5055, USA. johnsonjm@helix.nih.gov

RESUMEN / SUMMARY:  - The human T-cell leukemia virus type 1 (HTLV-1)